29121-56-0 Usage
Uses
Used in Pharmaceutical Synthesis:
2-(4-Hydroxy-3-methylphenyl)acetic acid is used as a key intermediate in the synthesis of pharmaceuticals for its versatile chemical properties. Its presence in fruits and vegetables, along with its antioxidant and anti-inflammatory properties, contribute to its potential use in developing new drugs for various medical applications.
Used in Organic Compound Production:
As an organic compound, 2-(4-Hydroxy-3-methylphenyl)acetic acid serves as an intermediate in the production of various organic compounds. Its unique structure and functional groups make it a valuable building block in the synthesis of a wide range of chemical products.
Used in Antioxidant Applications:
Due to its antioxidant properties, 2-(4-Hydroxy-3-methylphenyl)acetic acid can be used in applications requiring protection against oxidative stress. This makes it suitable for use in the development of nutraceuticals, dietary supplements, and other health-related products that aim to combat the harmful effects of free radicals.
Used in Anti-Inflammatory Applications:
The anti-inflammatory properties of 2-(4-Hydroxy-3-methylphenyl)acetic acid make it a potential candidate for use in the development of drugs and treatments for inflammatory conditions. Its ability to modulate inflammatory responses could lead to new therapeutic options for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 29121-56-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,1,2 and 1 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 29121-56:
(7*2)+(6*9)+(5*1)+(4*2)+(3*1)+(2*5)+(1*6)=100
100 % 10 = 0
So 29121-56-0 is a valid CAS Registry Number.
29121-56-0Relevant academic research and scientific papers
DDR2 INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS
-
, (2014/03/25)
The present invention relates to compounds of the formula (I) and in particular medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological states in the triggering
Compounds and methods for modulation of estrogen receptors
-
, (2008/06/13)
Compounds that modulate the estrogen receptor (ER) are disclosed, as well as pharmaceutical compositions containing the same. In a specific embodiment, the compounds are selective for ER-β over ER-α. Methods are disclosed for modulating ER-β in cell and/o
Compounds and methods for modulation of estrogen receptors
-
, (2008/06/13)
Compounds that modulate the estrogen receptor (ER) are disclosed, as well as pharmaceutical compositions containing the same. In a specific embodiment, the compounds are selective modulators for ER-β over ER-α. Methods are disclosed for modulating ER-β in
Process for producing hydroxyphenyl aliphatic acid derivatives
-
, (2008/06/13)
A catalyst of bis(8-quinolinolate) copper (II) complex having the formula STR1 which is used for producing a hydroxyphenyl aliphatic acid derivative having the formula STR2 wherein R1 represents hydrogen atom, a lower alkyl group, a lower alkoxy group, hydroxy group or a lower alkylcarbonyl group; R2 and R3 are the same or different and respectively represent hydrogen atom or a lower alkyl group; and m is 1 or 2; l is 0, 1 or 2; n is 0, 1 or 2; by reacting a halophenyl aliphatic acid derivative having the formula STR3 wherein R1, R2, R3, m, l and n are defined above and R4 represents hydrogen atom or a monovalent hydrocarbon moiety; and X represents a halogen atom, with a base.
